Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Broda (salicylic acid)
- Development stage
- Unknown
- Lead developer
- Broda Technologies
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Broda is a specialized formulation of salicylic acid that utilizes supramolecular technology to improve solubility and skin tolerability. Developed by Shanghai Broda Pharmaceutical Technology, this formulation employs host-guest chemistry to create a water-soluble complex of salicylic acid, which traditionally requires organic solvents like ethanol for stabilization at high concentrations. This technology aims to enhance the delivery of the active ingredient while significantly reducing the irritation, redness, and "frosting" often associated with conventional salicylic acid peels. Broda is primarily used for professional chemical peeling in the treatment of acne vulgaris, melasma, and sensitive skin syndrome. It is frequently evaluated in clinical settings for its efficacy when combined with physical modalities like gold microneedle radiofrequency to improve skin texture and barrier function.
- Brand names
- Broda
- Other names
- supramolecular salicylic acid博乐达
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Broda (salicylic acid).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Broda (salicylic acid).